Current Pharmaceutical Design,
Journal Year:
2024,
Volume and Issue:
31(6), P. 413 - 421
Published: Oct. 14, 2024
Ulcerative
Colitis
(UC)
known
as
a
sub-category
of
Inflammatory
Bowel
Diseases
(IBD)
is
longterm
condition
that
causes
inflammation,
irritation,
and
ulcers
in
the
colon
rectum.
Though
precise
pathogenesis
UC
not
fully
understood
yet,
impaired
immune
responses
imbalanced
intestinal
microbiome
composition
have
been
regarded
two
main
key
players
colitis
pathobiology.
As
conventional
treatments
are
challenged
with
limitations
side
effects,
finding
new
therapeutic
approach
has
gained
increasing
attention.
Probiotic
bacteria
multifunctional
health-promoting
properties
considered
novel
options.
There
strong
evidence
indicating
probiotics
exert
their
effects
mostly
by
regulating
system
restoring
gut
homeostasis.
These
results
validate
rationale
behind
clinical
application
management
whether
prescribed
alone
or
combination
therapy.
This
article
explores
UC,
concentrating
on
influence
dysregulation
imbalances.
Also,
it
reviews
recent
<i>in
vitro,
vivo</i>,
studies
demonstrated
efficacy
<i>Lactobacillus</i>
species
decreasing
symptoms
modifying
responses,
microbiota
balance,
promoting
barrier
function.
Pathogens,
Journal Year:
2024,
Volume and Issue:
13(8), P. 646 - 646
Published: July 31, 2024
Clostridioides
difficile
is
the
main
causative
agent
of
antibiotic-associated
diarrhea
(AAD)
in
hospitals
developed
world.
Both
infected
patients
and
asymptomatic
colonized
individuals
represent
important
transmission
sources
C.
difficile.
infection
(CDI)
shows
a
large
range
symptoms,
from
mild
to
severe
manifestations
such
as
pseudomembranous
colitis.
Epidemiological
changes
CDIs
have
been
observed
last
two
decades,
with
emergence
highly
virulent
types
more
numerous
CDI
cases
community.
interacts
gut
microbiota
throughout
its
entire
life
cycle,
difficile’s
role
colonizer
or
invader
largely
depends
on
alterations
microbiota,
which
itself
can
promote
maintain.
The
restoration
healthy
state
considered
potentially
effective
for
prevention
treatment
CDI.
Besides
fecal
transplantation
(FMT),
many
other
approaches
re-establishing
intestinal
eubiosis
are
currently
under
investigation.
This
review
aims
explore
current
data
consideration
recent
types,
an
overview
microbial
interventions
used
restore
human
microbiota.
Mycoses,
Journal Year:
2025,
Volume and Issue:
68(1)
Published: Jan. 1, 2025
ABSTRACT
A
niche
in
the
context
of
microorganisms
defines
specific
ecological
role
or
habitat
inhabited
by
microbial
species
within
an
ecosystem.
For
human
commensal
Malassezia
,
skin
surface
is
considered
its
primary
niche,
where
it
adapts
to
environment
utilising
lipids
as
main
carbon
and
energy
source.
However
pathogenic
characteristics
include
production
allergens,
immune
modulation
excessive
lipid
utilisation,
which
result
several
diseases
such
pityriasis
versicolor,
seborrheic
dermatitis,
folliculitis
atopic
dermatitis.
Recent
studies
have
revealed
colonisation
internal
organs,
including
lungs,
gut,
genitourinary
tract,
eyes,
ears
breast
milk.
In
these
associated
with
linked
respiratory
conditions,
neurological
disorders,
gastrointestinal
genital
infections.
The
system
plays
a
critical
shaping
prevalence,
factors
like,
suppressive
drugs
underlying
health
conditions
influencing
susceptibility.
Accurate
diagnosis
‐related
disorders
challenging
due
unique
growth
requirements,
but
molecular
fingerprinting
assays
sequencing
methods,
particularly
ITS
sequencing,
offer
precise
identification.
Treatment
involves
antifungal
drugs,
corticosteroids
phytocompounds,
yet
recurrent
infections
highlight
need
for
more
targeted
therapeutic
strategies
addressing
's
characteristics.
Understanding
complex
interactions
between
host
organs
crucial
diagnosis,
treatment
prevention
exploring
potentially
beneficial
roles
disease.
This
review
highlights
current
findings
on
intricate
diverse
ecosystem
body,
underscoring
complexity
associations
emphasising
their
multifaceted
Gastrointestinal Disorders,
Journal Year:
2025,
Volume and Issue:
7(1), P. 9 - 9
Published: Jan. 18, 2025
Background/Objectives:
The
gut–liver
axis
is
bidirectional
and
influences
the
body’s
homeostasis.
Pathologies
such
as
metabolic
dysfunction-associated
steatotic
liver
(MASL)
can
have
detrimental
effects
on
human
microbiome,
with
multiple
systemic
effects.
Furthermore,
geographical
particularities
of
intestinal
microbiome
may
influence
disease.
study’s
outcome
was
to
identify
dysbiosis
in
a
group
patients
MASL
from
western
region
Romania.
Methods:
NGS
shotgun
genomic
sequencing
(WGS
metagenomics)
method
used
bacteria
fecal
samples.
data
were
analyzed
using
IBM
SPSS
Statistics
software
[version
29.0.2.0
(20)].
Results:
Out
122
included
study,
43
(35.24%)
exhibited
low
alpha
diversity.
In
subgroup
normal
biodiversity
index,
approximately
half
identified
Firmicutes/Bacteroidetes
ratio
below
lower
reference
value,
while
remaining
presented
based
decreased
concentrations
Proteobacteria
Prevotella,
considered
among
most
relevant
species
supporting
dysbiosis.
A
higher
prevalence
Prevotella
(15.99
±
13.65%)
study
cohort.
Conclusions:
present
demonstrates
that
Romania
exhibit
criteria
for
dysbiosis,
namely
reduced
bacterial
diversity,
along
significant
alterations
populations
Firmicutes,
Bacteroidetes,
Proteobacteria,
Prevotella.
Together,
these
findings
suggest
possible
geo-cultural
factors
highlighting
need
regionally
adapted
therapeutic
interventions
support
health.
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(2), P. 138 - 138
Published: Feb. 1, 2025
Background/Objectives:
Drug-induced
dysbiosis,
particularly
from
antibiotics,
has
emerged
as
a
significant
contributor
to
chronic
diseases
by
disrupting
gut
microbiota
composition
and
function.
Plant-derived
secondary
metabolites,
such
polysaccharides,
polyphenols,
alkaloids,
saponins,
show
potential
in
mitigating
antibiotic-induced
dysbiosis.
This
review
aims
consolidate
evidence
preclinical
studies
on
the
therapeutic
effects
of
metabolites
restoring
microbial
balance,
emphasizing
their
mechanisms
efficacy.
Methods:
A
narrative
was
conducted
using
PubMed,
Scopus,
Web
Science.
Studies
were
selected
based
specific
inclusion
criteria,
focusing
animal
models
treated
with
for
The
search
terms
included
“gut
microbiota”,
“antibiotics”,
“secondary
metabolites”.
Data
extraction
focused
alterations,
metabolite-specific
effects,
action.
Relevant
findings
systematically
analyzed
summarized.
Results:
Secondary
demonstrated
diverse
impact
dysbiosis
modulating
composition,
reducing
inflammation,
supporting
host
biological
markers.
Polysaccharides
polyphenols
restored
Firmicutes/Bacteroidetes
ratio,
increased
beneficial
taxa
Lactobacillus
Bifidobacterium,
suppressed
pathogenic
bacteria
like
Escherichia-Shigella.
Metabolites
triterpenoid
saponins
enhanced
barrier
integrity
upregulating
tight
junction
proteins,
while
alkaloids
reduced
inflammation
proinflammatory
cytokines
(e.g.,
TNF-α,
IL-1β).
These
also
improved
short-chain
fatty
acid
production,
which
is
crucial
systemic
health.
While
primary
focus,
other
drug
classes
PPIs,
metformin)
require
further
investigation.
Conclusions:
promise
managing
improving
Future
research
should
explore
applicability
types
drug-induced
validate
human
enhance
clinical
relevance.
Indian Journal of Neurosurgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Abstract
Traumatic
brain
injury
(TBI)
has
profound
effects
that
extend
beyond
the
brain,
affecting
other
body
systems
via
secondary
pathways
and
leading
to
various
complications,
including
gastrointestinal
(GI)
dysfunction
during
after
hospitalization.
While
advances
in
TBI
management
have
improved
overall
outcomes,
absence
of
effective
treatments
for
these
systemic
highlights
urgent
need
innovative
therapeutic
strategies.
A
critical
aspect
this
context
is
brain–gut
axis
(BGA),
a
bidirectional
communication
network
connecting
GI
system
through
complex
neuronal,
hormonal,
immune
pathways.
results
increased
intestinal
permeability
hypercatabolic
state
bacterial
translocation,
dysregulation,
septic
multiorgan
failure.
These
complications
significantly
heighten
risk
morbidity
mortality
patients.
Emerging
evidence
suggests
gut
dysbiosis
plays
pivotal
role
post-TBI
complications.
The
microbiome,
diverse
community
commensal
microorganisms,
integral
physiology,
performing
key
functions
such
as
metabolic
regulation,
maintaining
barrier,
modulating
responses.
Disruptions
microbiota
can
exacerbate
dysfunction,
potentially
severe
outcomes.
This
review
examines
mechanisms
underlying
BGA
following
TBI,
focusing
on
contributing
dysregulation.
Additionally,
it
discusses
strategies
aimed
at
mitigating
dysbiosis.
Potential
interventions
include
approaches
restore
microbial
balance,
enhance
barrier
integrity,
support
modulation.
By
targeting
areas,
therapies
may
reduce
improve
patient
The
gut
biome,
a
complex
ecosystem
of
micro-
and
macro-organisms,
plays
crucial
role
in
human
health.
A
disruption
this
evolutive
balance,
particularly
during
early
life,
can
lead
to
immune
dysregulation
inflammatory
disorders.
‘Biome
repletion’
has
emerged
as
potential
therapeutic
approach,
introducing
live
microbes
or
helminth-derived
products
restore
balance.
While
helminth
therapy
shown
some
promise,
significant
challenges
remain
optimizing
clinical
trials.
Factors
such
patient
genetics,
disease
status,
species,
the
optimal
timing
dosage
their
metabolites
must
be
carefully
considered
train
system
effectively.
We
aim
discuss
how
helminths
induce
trained
immunity
prospective
treat
autoimmune
diseases.
molecular
repertoire
excretory/secretory
(ESPs),
which
includes
proteins,
peptides,
lipids,
RNA-carrying
extracellular
vesicles
(EVs),
underscores
modulate
innate
cells
hematopoietic
stem
cell
precursors.
Mimicking
natural
delivery
mechanisms
like
synthetic
exosomes
could
revolutionize
EV-based
therapies
production
ESP
will
for
translation
into
applications.
By
deciphering
harnessing
products’
diverse
modes
action,
we
unleash
full
pave
way
innovative
treatments.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 16, 2024
Dysbiosis,
an
imbalance
in
microbial
communities,
significantly
impacts
the
health
and
functionality
of
human
genital
tract,
with
profound
implications
for
fertility
reproductive
health.
This
review
explores
intricate
relationship
between
tract
microbiota
outcomes,
highlighting
composition
dynamics
these
communities
both
females
males.
In
females,
vaginal
microbiota,
primarily
dominated
by
Lactobacillus
species,
is
essential
maintaining
a
healthy
environment,
preventing
infections,
supporting
functions.
males,
influences
sperm
quality
Dysbiosis
manifesting
as
bacterial
vaginosis,
yeast
urethritis,
or
prostatitis,
disrupts
leading
to
adverse
outcomes
such
infertility,
pregnancy,
increased
susceptibility
sexually
transmitted
infections.
delves
into
mechanisms
through
which
dysbiosis
affects
fertility,
including
alterations
pH,
mucosal
immunity,
inflammation,
viability,
motility.
It
also
evaluates
diagnostic
methods,
clinical
implications,
management
strategies,
probiotics,
prebiotics,
antibiotics,
antifungal
treatments,
lifestyle
interventions,
emerging
therapeutic
approaches.
By
understanding
landscape
its
impact
on
this
aims
inform
targeted
interventions
that
restore
balance
enhance
health,
ultimately
improving
potential
pregnancies.
The
human
gut
is
abundantly
populated
with
structurally
complex
symbiotic
microbiota
that
metabolize
small
metabolites
generated
during
the
metabolism
of
food
and
exogenous
substances.
Various
are
produced
by
digestion,
including
short-chain
fatty
acids
(SCFAs),
amino
acids,
bile
indole
derivatives,
tryptophan
trimethylamine
N-oxide,
taken
up
blood,
activate
signaling
pathways,
ultimately
manipulate
physiological
processes.
dysbiosis
associated
liver
disease
(non-alcoholic),
cardiovascular
disease,
depression,
sleep
disorders,
atherosclerosis,
anxiety,
arthritis,
type
2
diabetes,
hypertension,
cancer,
autism,
gout.
influence
on
health
has
been
studied
for
last
two
decades.
Ingesting
unhealthy
foods
leads
to
variation
in
composition
barrier,
leading
mild
inflammation
metabolic
disorders.
By
understanding
interactions
host
its
impact
modulation
host's
functions,
it
assists
manipulation
combat
prevent
In
this
chapter,
we
will
discuss
alteration
microbiota,
altered
development
diseases,
composition,
production
pro-inflammatory
inflammatory
compounds
treat
diseases.